Cargando…
Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
Immune checkpoint inhibitors (ICIs) have shown definite therapeutic effects in various types of cancers, especially non-small cell lung cancer (NSCLC). However, ICIs have unique side effects, called immune-related adverse events (irAEs), which can occur in various systems throughout the body. Among...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424849/ https://www.ncbi.nlm.nih.gov/pubmed/36052257 http://dx.doi.org/10.3389/fonc.2022.911906 |